Care Village planned for elderly Kent patients

by JoelLane 2. October 2012 14:38

old_eyes_public_domain_pictures Specialist care village company English Villages is planning to build a care village with medical and social facilities for elderly patients near Maidstone, Kent.

The village will include 36 residential care beds and 99 close care and assisted living apartments, a wellness centre and a range of day care facilities.

Pending local government approval, the new site at Ledian Farm, Leeds Village will open in 2015 with over 100 care staff.

The wellness centre will provide rehabilitation and physiotherapy services, and will include a treatment room staffed by GPs.

Keith Cockell, Managing Director, noted that 16,000 people aged over 80 live within a short drive of the site, and this figure is expected to double by 2030.

“We have taken into account the demographics and the desires of the local community to deliver a balanced and sustainable community facility,” he said.

“The Village represents a multi million pound investment in services and facilities for older people and those in need of care living in the area.”

The care village represents a private sector response to the growing need among elderly patients for integrated health and social care.

The commissioning landscape

by IainBate 30. August 2012 13:00

After April 2013, who will commission which health services?

The Commissioning landscape - Pharmaceutical Field The new NHS structure is designed to promote integrated care by making the roles of a number of different commissioners interlock. The GP-led clinical commissioning groups (CCGs) are the core of the system, responsible for dealing with most areas of patient need in the local community. Around that, however, three other commissioning bodies are engaged with supporting patient health and wellbeing:

  • the NHS Commissioning Board (NHSCB) is responsible for primary care and specialised services
  • local authorities are responsible for improving public health
  • Public Health England (PHE) is responsible for protecting and promoting health though intervention in health and social care services and public awareness.

A map of services

The Commissioning Board Authority’s Commissioning fact sheet for clinical commissioning groups maps the new health landscape by comparing the responsibilities of the four organisations. For each new commissioner, it lists the main functions and the similarities to other commissioners – thereby making the point that service integration is vital for effective care.

The fact sheet states that CCGs will need to work collaboratively with local authorities and the NHSCB – and that to do so, they may pool budgets or have joint commissioning arrangements. For example, it is suggested that responsibility for sexual health and for addiction-related services will need to be divided between the CCG and the local authority to avoid duplications or gaps in provision.

Clearly, the matrix of healthcare is a dynamic one that can be interpreted by local commissioners in a range of ways. The map is not a final one in any case: some details, including the specialised services covered by the NHSCB, are still to be confirmed by Parliament in the autumn.

Community healthcare

The fact sheet compares the responsibilities of CCGs and the NHSCB for commissioning patient care. It notes that local authorities will provide “public health advice” to CCGs, but will not commission at that level. The role of local authorities in commissioning social care is not covered, but is a further dynamic that CCGs will need to be aware of.

The core elements of CCG commissioning relate to: emergency care; out-of-hours primary medical care (where not covered by the GP contract); elective hospital care; community health (such as physiotherapy and continence services, but not health visiting or family nursing); rehabilitation; maternity and newborn care (except where intensive); paediatric care; mental health and learning disability care; and infertility treatment.

The core elements of NHSCB commissioning relate to: primary care through the GP contract; community pharmacy; primary ophthalmic care; all dental care; health services for people in prisons and other custodial institutions; health services for members of the armed forces; and specialised services.

The fact sheet draws out some detailed differences between the two lists in order to avoid confusion – for example, noting that health services for offenders in the community are covered by CCGs. Sometimes, as where the GP contract varies, certain services may be commissioned by the CCG in some localities and by the NHSCB in others. None the less, overall there is a clear division of responsibilities.

Public health services

With the commissioning of public health services, the picture is significantly more complex. Responsibility is divided between the NHSCB, the local authority and Public Health England. In some cases – notably immunisation programmes – these services can relate to provision of medication. In other cases – notably epidemic preparedness – they can relate significantly to medicines management and other aspects of primary and secondary NHS care.

Public health services to be commissioned by the NHSCB include services for children from pregnancy to age 5. This responsibility will transfer to local authorities in 2015. It covers health visiting, family nurse partnership and responsibility for child health data. The NHSCB will also be responsible for immunisation and national screening programmes – both being areas of increasing NHS spend, as evidenced by recent investment in cervical cancer and prostate cancer screening and in vaccines against HPV and influenza. With hepatitis C vaccines on the market and HIV vaccines a real prospect, this area of medication will become increasingly crucial for the NHS.

Local authorities will be responsible for providing or commissioning a wide range of public health services that relate mostly to preventative measures and raising awareness, including: children’s public health for ages 5 to 19; sexual health; public mental health; obesity management; drugs, alcohol and smoking services; dental public health; and seasonal mortality. Active medical intervention, including medication, features strongly in the sexual health and drug, alcohol and smoking services to be provided; the transfer of sexual health services from NHS to local authority control is a major change in the provision of UK healthcare. Notably, however, HIV treatment will be commissioned by the NHSCB.

PHE is taking over the functions of the Health Protection Agency and will impact significantly on the health protection activities of CCGs, the NHSCB and local authorities. Sometimes all relevant health stakeholders will work together – for example, PHE has a strategic role in influenza and other epidemic preparedness, to which local authorities, CCGs and the NHSCB will contribute. PHE’s role also covers behaviour change campaigns around early diagnosis and other issues; public oversight of infection prevention and control; and general intelligence on health protection and improvement, including the current functions of the Cancer Registries. These initiatives will also impact on GP services.

Joined-up care

CCGs will be the glue in the new healthcare commissioning system: the first port of call when gaps or inequalities in service provision arise. While they cannot commission GP care, their close professional connection to it should ensure that what impacts on CCGs will be taken to heart by GPs. But given that austerity measures will dominate the NHS for the “foreseeable future” (in David Nicholson’s words), it is inevitable that funding and staffing shortages will create holes in the patchwork of the new health system. The pharmaceutical industry will thus need to be alert to partnership opportunities opening up at local and national levels.

Essex gains specialist dementia unit

by JoelLane 29. August 2012 14:21

dementia A new specialist unit will give dementia patients in south Essex a halfway house between hospital and home, easing the transfer of care.

The Mountnessing Court healthcare facility in Billericay will be developed into a short-stay dementia treatment unit with 22 beds.

The flagship integrated care facility will bring doctors, nurses and therapists together with social care and mental health professionals, as well as Alzheimer’s Society workers.

A specialised care environment designed for people with dementia, it will provide 24-hour intensive treatment for patients staying up to eight weeks as a bridge between secondary care and independent life at home.

It will also treat patients being treated concurrently for a dementia and another medical problem, and will provide support for family carers of dementia patients.

The centre will be trialled from this autumn until January 2013. Patients will be drawn from Basildon, Thurrock , Rochford and Castle Point.

Ian Stidston, Director of Primary Care and Partnership Commissioning at NHS South Essex, said the unit would enable people “to have intensive support away from hospital” and that its purpose was to help patients “stay at home and live as independently as possible, for as long as possible”.

The Mountnessing Road facility was previously used as a day-care centre for elderly people with mental illness. It was faced with closure, but instead will be redeveloped as a specialist unit.

New NHS prosthetic centres for military veterans

by emma 28. October 2011 11:42

Medtech NHS News

The Government is investing up to £15m to develop specialist prosthetic and rehabilitation centres for military veterans who have lost a limb in service.

Following a review led by Dr Andrew Murrison MP, the programme aims to improve the NHS prosthetic services available to veterans – and ultimately to all amputees in the UK.

The Government will work with service charities and clinical specialists to bring together innovative prosthetic technologies and support services.

Up to £15m has been committed from 2012–2015 to support the measures recommended by the Murrison report, including:

  • National commissioning of specialist prosthetic and rehabilitation services for amputee veterans through a small number of multi-disciplinary centres in England.
  • Equivalent and complementary NHS provision to be available to veterans through a Disablement Services Centre (DSC) of their choice.
  • A refined system of case management, including a comprehensive statement of needs and prescription on transition to the NHS.
  • NICE to produce national guidelines for prosthetic prescription and rehabilitation for all amputees.
  • The Defence Medical Rehabilitation Centre at Headley Court to become part of a Defence and National Rehabilitation Centre more closely integrated with the NHS.
  • A programme of military-civilian exchange and capacity building to develop the specialist prosthetic and rehabilitation network.

“As a country and as a Government we have a particular duty to servicemen and women injured on operational duty,” said Prime Minister David Cameron. “This report maps out a clear strategy for ensuring that those brave people can be confident they will receive the same levels of access to prosthetic limbs and specialist care from the NHS as they do at Headley Court.”

Dr Andrew Murrison MP commented: “I hope the action points I have offered honour the military covenant and benefit military amputees, but I have been clear that they should also help to improve the service available to all limb centre users.”

Double approval for Bioness’ hand paralysis system

by emma 6. October 2011 14:00

MB product news

US rehabilitation therapy company Bioness has received CE Mark Approval and FDA clearance for its Ness H200 Wireless system for hand paralysis patients.

The advanced wireless hand rehabilitation device uses mild Functional Electrical Stimulation (FES) to help patients to grasp and release objects while performing daily life activities.

The Ness H200 Wireless system aims to improve hand function, increase therapy time and encourage motor recovery in those suffering from hand paralysis resulting from stroke or other central nervous system disorders.

Todd Cushman, Senior Vice President of Global Business Development and Marketing for Bioness, said: “It is well known in rehabilitation that frequency of therapy and training has a direct impact on outcomes. Simply put, the more patients are able to be active and integrate therapy into their day to day lives, the better their outcomes.”

The device consists of three components: a wireless, lightweight stimulation support (orthosis); a small handheld remote that communicates wirelessly with the system; and a clinician’s programmer that allows patient activity tracking.

The company expects the equipment will become commercially available to neurorehabilitation hospitals and centres in the US and Europe, as well as to consumers for home use, later this year.

Based in California, Bioness specialises in neurostimulation devices to restore mobility and independence to people suffering from nerve damage.

Online Sling Selector supports clinicians

by emma 4. October 2011 14:58

Sling Selector

Oxford, a division of patient lift provider Joerns Healthcare, has launched an online Sling Selector to help healthcare professionals select the best sling option for patients.

The online tool takes account of patient specifics, the transfer task, the safe working load and the lift to be deployed.

The Oxford Sling Selector (pictured) was demonstrated at the National Back Exchange (NBE) Conference and Exhibition 2011 in Hinckley.

The tool comes with an on-screen guide to answer any queries that arise during the selection process. It provides detailed sling information and has an account history to track patient sling usage.

Tom Bulpitt, Marketing Manager for Joerns Healthcare, said: “Selecting the most appropriate sling is crucial since it ensures a safe, dignified and comfortable patient transfer while reducing the risks associated with manual handling.

“The Oxford Sling Selector will be of particular help to those clinicians less familiar with sling equipment such as junior or trainee occupational therapists, physiotherapists and back care advisors.”

During the NBE conference Joerns demonstrated the educational tool on its exhibition stand in the main hall and during an in-depth training workshop.

The Oxford Sling Selector is free to access by all professionals and can be located at its own dedicated website or via the Resources section on the main Joerns UK website.

Oxford is an established supplier of patient handling and rehabilitation products and a division of Joerns Healthcare, an international brand with offices in the UK, the US, Canada and the Netherlands.

Pain therapy device approved in US

by emma 27. September 2011 16:52

MB product news

The FDA has granted US approval to Zynex for NexWave, a medical device to be used in electrotherapy treatment.

The next generation medtech system combines three modes of medical technology to provide a wide range of pain and muscle rehabilitation therapies: traditional TENS, interferential and neuromuscular electrical stimulation – through one non-invasive device.

Thomas Sandgaard, CEO of Zynex, said: “The combined modalities of our NexWave provide doctors and clinicians a more comprehensive pain therapy solution for their patients. This device was designed with the patient in mind, as it is compact and easy to use.”

US-based Zynex Medical engineers and manufactures its own design of electrotherapy medical devices for pain relief, pain management and stroke and spinal cord injury rehabilitation.

TextBox

Tag cloud

RecentPosts

Calendar

<<  May 2013  >>
MoTuWeThFrSaSu
293012345
6789101112
13141516171819
20212223242526
272829303112
3456789

View posts in large calendar